Arrowhead Pharmaceuticals Inc CFO Kenneth Myszkowski Sells 16,104 Shares
Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) CFO Kenneth Myszkowski sold 16,104 shares of the company's stock on January 5, 2024, according to a SEC Filing.
Source: yahoo.com
Page 2 - Rna Interference News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Rna Interference. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Rna Interference Today - Breaking & Trending Today
Switch Therapeutics Appoints Charles Allerson, Ph.D., as Chief Technology Officer
SOUTH SAN FRANCISCO, Calif., January 03, 2024--Switch Therapeutics today announced the appointment of Charles Allerson, Ph.D., as Chief Technology Officer (CTO).
Source: yahoo.com
RNA Based Therapeutics Market Is Projected to Gain $25,121.95 Million by 2030: Allied Market Research
The global RNA therapeutics market is driven by the increasing number of government initiatives for large-scale sequencing projects, target specificity, and selectivity of treatment.Wilmington, Delaware, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, “RNA Based Therapeutics Market by Disease Type (RNA antisense and RNA interference (RNAi)), Application (Auto-Immune Disorders and Genetic Disorders) and End User (Hospitals & Clinics and Research Institutes): G
Source: yahoo.com
Stockholm University Breakthrough in Extinct Species RNA
Dublin, Oct. 16, 2023 (GLOBE NEWSWIRE) -- In an astounding revelation, scientists at Stockholm University have achieved a first-of-its-kind feat by...
Source: globenewswire.com
Insider Sell: CEO Christopher Anzalone Sells 57,755 Shares of Arrowhead Pharmaceuticals Inc
On September 18, 2023, Christopher Anzalone, the CEO of Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR), sold 57,755 shares of the company.
Source: yahoo.com